vimarsana.com

Page 7 - கிருஷ்ணா நிறுவனம் ஆஃப் மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Market Ahead Podcast, June 28: Factors that could guide markets this week

Macroeconomic data, the pace of vaccination, auto sales and global trends would be the major drivers for the domestic equity markets this week, analysts said. Besides, the progress of the monsoon will also remain on investor radar. The benchmark indices had ended the eventful week over 1% higher and analysts remain cautiously optimistic on further upmove in the market, although a third wave of Covid can dent sentiments, they say. While the number of Covid cases in India is on a downtrend, concerns about a new Covid variant loom. India in the last 24 hours reported cases a little over 50,000. The pace of vaccination in the country, too, has picked up the pace with some 4 crore jabs administered last week. Investors will keep a close watch on the vaccination pace and Covid cases going ahead.

Stocks to watch: Dodla Dairy, KIMS, Barbeque Nation, Thyrocare, SBI, Lupin

Here are the top stocks to track in today s session: Dodla Dairy, KIMS: Two companies will list on the bourses on Monday, namely Dodla Dairy and Krishna Institute of Medical Sciences (KIMS). The two IPOs that ran between June 16-18 were subscribed 46 times and 4 times, respectively. Earnings Today: More than 300 companies are slated to post their quarterly numbers today including NALCO, Future Lifestyle, Zee Media, GIC Housing Finance and NLC India. IndiGo: Shareholders of InterGlobe Aviation, parent of airline IndiGo, have approved a proposal to raise up to Rs 3,000 crore. The funds would be raised through the Qualified Institutional Placement route.

Dodla Dairy, KIMS, Thyrocare Technologies in spotlight

Shares of Dodla Dairy will debut on the bourses today, 28 June 2021. Dodla Dairy offer closed for subscription on June 18 after being subscribed 45.62 times. Issue price is Rs 428 per share. Shares of Krishna Institute of Medical Sciences (KIMS) will debut on the bourses today, 28 June 2021. KIMS Hospitals public offer witnessed an oversubscription of 3.86 times during June 16-18. Issue price is Rs 825 per share. Reliance Industries (RIL) said that the Fluidized Catalytic Cracker Unit (FCCU) in SEZ refinery at Jamnagar which was taken for an emergency shutdown on June 6, 2021 has been restarted after carrying out necessary repairs. The Unit has since been stablized and normal throughput has been reached.

KIMS share price: KIMS lists at 22% premium over issue price of Rs 825

KIMS) made a strong debut on Monday, as the stock got listed at Rs 1008.90 on BSE, a 22.29 per cent premium over its issue price of Rs 825. On NSE, the scrip debuted at Rs 1,009, up 22.30 per cent from issue price. Seasoned investor Ashish Kacholia, known for his ability to pick quality midcap and smallcap, had placed an application for over two million shares worth about Rs 180 crore in the initial public offering. The Rs 2,144 crore IPO was sold between June 16 and 18. It received bids for 5,56,55,046 shares compared with 1,44,13,073 shares on offer. The quota reserved for qualified institutional buyers(QIBs) was subscribed 5.26 times, the one for non-institutional investors received 1.89 times bids while the quota reserved for retail individual investors (RIIs) was subscribed to 2.89 times.

KIMS Hospitals lists at 22 per cent premium over issue price

Krishna Institute of Medical Sciences (KIMS) made a good debut at the bourses, on Monday, with the stock listing at Rs 1,009, up 22 per cent against its issue price of Rs 825 per share on the National Stock Exchange (NSE). At 10:06 am, the stock was trading at Rs 1,003, after hitting a low of Rs 990 on the NSE and BSE. A combined 4.38 million shares have changed hands on the counter on both the exchanges, so far. KIMS is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of the number of patients treated and treatments offered. It operates nine multi-specialty hospitals under the KIMS Hospitals brand, with an aggregate bed capacity of 3,064, including over 2,500 operational beds as of March 31, 2021.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.